Novo Nordisk raises Metsera bid again, hoping to top Pfizer’s latest offer

No­vo Nordisk has once again upped its bid for Met­sera, ac­cord­ing to sources fa­mil­iar with the mat­ter, in an ef­fort to beat out a raised …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.